Befejeződött1/2. fázis
A phase I study of [177Lu]Lu-FF58 in patients with advanced solid tumors
Key facts
- Where
- Barcelona, L'Hospitalet de Llobregat és Madrid, SpanyolországSee the 4 sites
- Phase
- 1/2. fázis
Where in Spanyolország
- Hospital Universitari Vall d'HebronBarcelona, SpanyolországNo longer taking part
- Institut Catala D'oncologiaL'Hospitalet de Llobregat, SpanyolországNo longer taking part
- Hospital Universitario 12 de OctubreMadrid, SpanyolországNo longer taking part
- Hospital Universitario Ramón y CajalMadrid, SpanyolországNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Novartis Pharma AG
- Trial code
- EU 2022-502367-37-00
- Record updated
- 2024. december 9.